Updated : Nov 14, 2019 in Announcement

Children’s National Hospital, Virginia Tech announce partnership for new Children’s National Research & Innovation Campus

Children’s National Hospital and Virginia Tech announce a formal partnership that will include the construction of a 12,000-square foot Virginia Tech biomedical research facility within…

Updated : Nov 13, 2019 in Announcement

LUDWIG LAUSANNE’S PING-CHIH HO NAMED AN EMBO YOUNG INVESTIGATOR

NOVEMBER 13, 2019, New York— Ludwig Cancer Research congratulates Ping-Chih Ho on his selection by the European Molecular Biology Association (EMBO) as a member of…

Updated : Nov 12, 2019 in Research Articles

Mount Sinai Researcher’s Examine the Metabolic Effects of an Oral Blood Cancer Drug

Contact: Kathryn Ullman                     Mount Sinai Press Office                     646-398-2065                     [email protected]   Mount Sinai Researcher’s Examine the Metabolic Effects of an Oral Blood Cancer…

Updated : Nov 08, 2019 in Research Articles

Approach to Personalizing Treatment of Triple-Negative Breast Cancer Shows Promise in Cell Lines

Triple-negative breast cancer is an aggressive cancer, one that’s likely to recur and to metastasize. It’s also quite diverse at the molecular level, and doctors…

Updated : Nov 06, 2019 in Announcement

MD Anderson, Artios Pharma and ShangPharma announce in-licensing agreement for DNA damage response inhibitor

HOUSTON, CAMBRIDGE, UK, NEW YORK and SOUTH SAN FRANSISCO -- The University of Texas MD Anderson Cancer Center, Artios Pharma Limited and ShangPharma Innovation today announce…

Updated : Nov 04, 2019 in Feature

Smilow Cancer Hospital expert explains five things you need to know about Lung Cancer

New Haven, Conn. — Lung cancer is the second most common cancer in both men and women in the United States. According to the American…

Updated : Nov 04, 2019 in Feature

Researchers investigate impact of actual and virtual nature on cancer patients

Researchers at Houston Methodist Cancer Center are exploring whether exposure to nature, through either a live garden or virtual reality, can alleviate pain and distress…

Updated : Nov 01, 2019 in Announcement

Nashville Predators to Honor Late CEO of Monroe Carell Jr. Children’s Hospital at Vanderbilt at Hockey Fights Cancer Game

When the Nashville Predators hockey team hits the ice Saturday, Nov. 2, the players will take on an important opponent: childhood cancer. The Hockey Fights…

Updated : Oct 31, 2019 in Research Articles

Study finds racial disparities in culturally competent cancer care

Non-white minority survivors are less likely than non-Hispanic whites to be seen by cancer specialists who share or understand their culture. The disparity is likely…

Updated : Oct 31, 2019 in Research Articles

LLNL leads multi-institutional team in modeling protein interactions tied to cancer

Computational scientists, biophysicists and statisticians from Lawrence Livermore National Laboratory (LLNL) and Los Alamos National Laboratory (LANL) are leading a massive multi-institutional collaboration that has…

Updated : Oct 28, 2019 in Research Articles

Treating the TOTAL patient: clinical trial reduces relapse

Despite modern therapies, 10% of patients with acute lymphoblastic leukemia (ALL) treated in the U.S. relapse, which dramatically reduces their chance of survival. Results from…

Updated : Oct 25, 2019 in Announcement

Major Grant for Study of Cell Fate in Cancer

Harvard Medical School researcher Peter Kharchenko and three collaborators have won a six-year multimillion-dollar grant from the European Research Council for their work toward mapping out cellular…

Updated : Oct 24, 2019 in Research Articles

Cancer treatment: researcher makes breakthrough immunotherapy discovery

Dr. Christopher E. Rudd, a researcher at the Centre de recherche de l'Hôpital Maisonneuve-Rosemont (CR-HMR) and Université de Montréal, has discovered a new cell therapy…

Updated : Oct 24, 2019 in Research Articles

Controlling the immune system’s brakes to treat cancer, autoimmune disorders

Immunologists at St. Jude Children’s Research Hospital have discovered key biological switches that control regulatory T cells—specialized white blood cells that keep the immune system…

Updated : Oct 23, 2019 in Research Articles

Study fingers new player in cancer immunity

The immune system must strike an exquisite balance between vanquishing infections and cancer, while at the same time restraining its activity to avoid inadvertently attacking…

Updated : Oct 21, 2019 in Announcement

UC San Diego Moores Cancer Center’s J. Silvio Gutkind Joins National Academy of Medicine

Considered one of the highest honors in the fields of health and medicine, J. Silvio Gutkind, PhD, Distinguished Professor of Pharmacology at University of California…

Updated : Oct 18, 2019 in Announcement

St. Jude Children’s Research Hospital and IAEA partner to tackle childhood cancers in developing countries

The International Atomic Energy Agency (IAEA) and St. Jude Children’s Research Hospital are joining forces to combat childhood cancers in developing countries, where children are…

Updated : Oct 17, 2019 in Feature

New Precision Immunotherapy Clinic Matches Patients to Latest Cancer Therapies

A third occurrence of colon cancer and a failed immunotherapy clinical trial left Gordon Levine confined to a wheelchair with large tumors in his right…

Updated : Oct 17, 2019 in Research Articles

MD Anderson and Varian partner to optimize radiation oncology treatment

HOUSTON and PALO ALTO, Calif. ― The University of Texas MD Anderson Cancer Center and Varian today announced a new strategic collaboration to develop an…

Updated : Oct 17, 2019 in Research Articles

Researchers Identify Targeted Therapy That Can Help Children With Deadly Nerve Cancer

(New York, NY – October 17, 2019) – Mount Sinai researchers have identified a targeted therapy for adolescent patients with neuroblastoma, a deadly pediatric nerve…

Updated : Oct 16, 2019 in Feature

UCLA opens pioneering CAR T clinical trial aimed at extending the lives of people diagnosed with the most common types of lymphoma and leukemia

Los Angeles – The field of immunotherapy has revolutionized the way people with incurable cancers are treated, saving the lives of many people whose disease…

Updated : Oct 15, 2019 in Announcement

A Conversation With a Living Legend in Dallas to honor LA Dodgers pitcher Clayton Kershaw

HOUSTON -- The North Texas A Conversation With a Living Legend® will honor Los Angeles Dodgers starting pitcher Clayton Kershaw in an interview with CBS…

Updated : Oct 14, 2019 in Announcement

Claus Torp Jensen Has Been Appointed First Chief Digital Officer and Head of Technology for Memorial Sloan Kettering Cancer Center

October 14, 2019, NEW YORK CITY — Memorial Sloan Kettering Cancer Center (MSK) today announced that Claus Torp Jensen, PhD, has joined the institution as…

Updated : Oct 10, 2019 in Research Articles

Cancer Patients Want to Pull Back the Curtain on Pathology

Some of the most important players on a cancer patient’s health care team are people they typically never meet or interact with — the pathologists…

Updated : Oct 04, 2019 in Research Articles

Microbiome Provides New Clues to Determining Development of Colon Cancer

A mutant protein found in humans with colon cancer blocks a pathway that regulates proliferation and expansion of cells, increasing amounts of bacterial species associated…

Updated : Oct 04, 2019 in Research Articles

NUS scientist designs ‘express courier service’ for immune cells

Immunotherapy is a promising cancer treatment that uses genetically modified immune cells to fight cancer. It can be used as a primary treatment or in…

Updated : Oct 03, 2019 in Research Articles

Patients say ask before using medical records for research

Oct. 3, 2019 For more information, contact: Nicole Fawcett, [email protected] 734-764-2220 For immediate release Patients say ask before using medical records for research Learning health…

Updated : Oct 03, 2019 in Feature Expert

Unique Issues for Young Women with Breast Cancer

Will I be able to have a baby? Will the treatment trigger early menopause? What about my sex life? Women under 40 who are diagnosed…

Updated : Oct 02, 2019 in Expert Pitch

The Blue in the Pink: Busting Myths about Male Breast Cancer

UNLV public health researcher Marya Shegog highlights study exploring survivor stories, stereotypes, and health care disparities during Breast Cancer Awareness Month. UNLV — As Breast…

Updated : Oct 02, 2019 in Research Articles

Study: Biomarker in Urine May Offer Non-invasive Detection of Prostate Cancer

DETROIT – A research study published in the journal Neoplasia and led by principal investigator Nallasivam Palanisamy, Ph.D., associate scientist in the Vattikuti Urology Institute…

Updated : Sep 29, 2019 in Research Articles

Adding targeted therapy drug to hormone therapy helps women with aggressive breast cancer live longer

ABSTRACT LBA7_PR A study led by UCLA researchers found that adding ribociclib, a targeted therapy drug, to standard hormone therapy has been shown to significantly…

Updated : Sep 28, 2019 in Research Articles

New blood test capable of detecting multiple types of cancer

A new blood test in development has shown ability to screen for numerous types of cancer with a high degree of accuracy, a trial of…

Updated : Sep 27, 2019 in Research Articles

Study shows nearly half of cancer patients who enter a comprehensive tobacco treatment program quit smoking

HOUSTON ― In the largest smoking cessation study of cancer patients to date, researchers from The University of Texas MD Anderson Cancer Center found that…

Updated : Sep 27, 2019 in Research Articles

Latest Global Immuno-Oncology Landscape Report from the Cancer Research Institute Published in Nature Reviews Drug Discovery

3,876 immuno-oncology therapies are in the global drug development pipeline worldwide, representing a 91% increase since 2017 205 new therapeutic targets have been added to…

Updated : Sep 25, 2019 in Research Articles

Researchers apply fat cells to deliver drug to suppress tumor growth

UCLA RESEARCH ALERT FINDINGS Researchers at the UCLA Jonsson Comprehensive Cancer Center have identified a new drug delivery pathway that may help stop tumor growth…

Updated : Sep 24, 2019 in Research Articles

Oncologists Respond Swiftly to FDA Safety Alerts, Penn Study Finds

PHILADELPHIA – Within six months of the U.S. Food and Drug Administration’s (FDA) move to restrict the label of two immunotherapies, usage of those therapies…

Updated : Sep 20, 2019 in Research Articles

Leukemia Drug Shows Promise for Treating a Childhood Brain Cancer

A drug used to treat chronic myeloid leukemia appears to be more effective at stopping a type of medulloblastoma in mouse models than existing treatments…

Updated : Sep 17, 2019 in Research Articles

Yale Cancer Center researchers show adding radiation after immunotherapy improves survival time for patients with advanced lung cancer

The results of a phase II clinical trial by Yale Cancer Center (YCC) researchers show adding high-dose radiation after immunotherapy stops working increases survival time…

Updated : Sep 17, 2019 in Research Articles

First Positive Results in 45 Years: Rhabdomyosarcoma Randomized Clinical Trial Led by Children’s Hospital Los Angeles

A phase 2 clinical trial has found that combining a molecular targeted drug called temsirolimus with chemotherapy shows promise in the treatment of rhabdomyosarcoma, the…

Updated : Sep 16, 2019 in Research Articles

Most American adults do not know that HPV causes oral, anal, and penile cancers

More than 70% of U.S. adults are unaware that human papillomavirus (HPV) causes anal, penile, and oral cancers, according to an analysis led by researchers…

Updated : Sep 13, 2019 in Feature Tip Sheet

Northwestern Medicine physicians, staff prepare to present at ASTRO 2019

CHICAGO – Sept. 13, 2019 –  Radiation oncologists and team members from the Northwestern Medicine Chicago Proton Center and Robert H. Lurie Cancer Center of…

Updated : Sep 13, 2019 in Research Articles

Cancer Protocols: A New Approach to Predicting Treatment Outcomes

Diversity – at least among cancer cells – is not a good thing. Now, research from the Weizmann Institute of Science shows that in melanoma,…

Updated : Sep 12, 2019 in Research Articles

Failed Cancer Drug Looks Promising For Scleroderma And Other Fibrotic Conditions

Sixteen years ago, a research group at Mayo Medical School published results showing that a protein called TRAIL can kill cells that cause liver fibrosis…

Updated : Sep 10, 2019 in Research Articles

Existing drug could treat aggressive brain cancer

Athens, Ga. –A research team from the University of Georgia’s Regenerative Bioscience Center has found that a compound molecule used for drug delivery of insulin…

Updated : Sep 10, 2019 in Expert Pitch

Rutgers Experts To Speak on the Continued Health Risks Faced by First Responders Ahead of 9/11 Anniversary

Rutgers Experts Available to Speak on the Continued Health Risks Faced by First Responders Ahead of 9/11 Anniversary New Brunswick, N.J., September 9 – Rutgers…

Updated : Sep 09, 2019 in Research Articles

Unmarried patients less likely to survive cancer as bias drives treatments

Unmarried patients with cancer are less likely to get potentially life-saving surgery or radiotherapy than their married counterparts, raising the concern that medical providers may…

Updated : Sep 06, 2019 in Feature

The Institute for Cancer Outcomes and Survivorship Focuses On Key Quality-Of-Life Issues

As more patients—adult and pediatric—become long-term cancer survivors, it becomes ever more imperative to identify ways to prevent, or at least manage, long-term complications from…

Updated : Sep 05, 2019 in Feature Expert

SCCA Experts Present Cancer Research at the ASCO Quality Care Symposium

SCCA Updates - September 3, 2019 if you are interested in learning more about any of these updates, please click here to contact us.  Dr. Ramesh Rengan Earns…

Updated : Sep 05, 2019 in Research Articles

Swallowable Device to Detect Pre-cancerous Barrett’s Esophagus Receives FDA 510(k) Clearance

Investigators at Case Western Reserve University School of Medicine, the Case Comprehensive Cancer Center and University Hospitals Cleveland Medical Center developed the test for early…

Updated : Sep 05, 2019 in Research Articles

Researchers Characterize Lung Inflammation Associated With Some Cancer Immnunotherapy

Immune checkpoint inhibitors are a type of therapy that uses the immune system to fight cancer. They have been hailed as game changing, garnering a…